dermatan sulfate has been researched along with Fibromuscular Dysplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brister, SJ; Buchanan, MR | 1 |
1 review(s) available for dermatan sulfate and Fibromuscular Dysplasia
Article | Year |
---|---|
A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.
Topics: Animals; Dermatan Sulfate; Endothelium, Vascular; Fibrinolytic Agents; Fibromuscular Dysplasia; Humans; Recurrence; Thrombin | 1999 |